American Academy of Family Physicians
About UsNews & PublicationsMembersCME CenterClinical & ResearchPractice MgmtPolicy & AdvocacyCareers

Flu Vaccine Supply Far Exceeds Last Year's Supply, Says CDC

By News Staff
9/13/2006

Although many health care professionals ran short of influenza vaccine or received delayed shipments last year, the same delays are not expected this year, according to a Sept. 6 news release from the CDC. Manufacturers are increasing the supply and speeding up deliveries, says the release.

Clinical Practice
Manufacturers and distributors plan "to provide some influenza vaccine by the end of October to all providers who ordered it," says the CDC. According to the release, manufacturers report they should produce more than 100 million doses of flu vaccine for the U.S. market this year, which is at least 17 million more doses than in other years and 19 million more doses than last year. Manufacturers also say about 75 million doses will be distributed by the end of October, compared to about 60 million by the end of October last year.

"When and how much vaccine each health care provider or clinic receives depends on who they ordered from and when they ordered," says Lance Rodewald, M.D., director of the CDC's Immunization Services Division, in the news release. "We expect that some health care providers and clinics may get or have more influenza vaccine than others in the first month or so, but people will have plenty of opportunities to be vaccinated during October and November, as well as December or later."

Many people can benefit from the vaccine, especially health care professionals, children between 6 months and 5 years old, people 50 years old and older, and people with chronic diseases, says Julie Gerberding, M.D., M.P.H., CDC director, in the release.

Clinical Care & Research

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women

FDA Revises Diabetes Drug Prescribing Information

H1N1 Vaccine Availability Increasing Slowly

ACIP Supports 'Permissive Use' of Gardasil in Males

CDC Survey Shows Overall Gains in Teens' Immunization Rates

FDA Approves Gardasil for Males, Bivalent HPV Vaccine for Girls, Women

New USP Standards for Heparin Decrease Unit Dose Potency

H1N1 Vaccine Deliveries Begin This Week

Clinical Trial of H1N1 in Kids, Teens Shows Mixed Results

Physicians Should Use Caution With Tamiflu Dosages

Prostate Cancer Awareness Campaigns Could Cause Confusion

Federal Health Officials Push H1N1 Vaccine for Adults, Health Workers

IOM: N95 Respirators Offer H1N1 Flu Defense for Health Personnel

CDC Updates Recommendations for Antiviral Use

CDC Updates Guidance on Ophthalmia Neonatorum Prophylaxis

New AHRQ Guides Outline Gestational Diabetes Treatment Options

Erythromycin Ophthalmic Ointment in Short Supply

CDC, FDA Study Reinforces Safety, Efficacy of Gardasil

New GSK Product Should Ease Hib Vaccine Shortage

H1N1 Vaccine Clinical Trials in Adults Free of Adverse Events

AAFP Launches Awareness Campaign for Pertussis Vaccination

H1N1 Vaccine Production Lagging Behind Expectations

FDA Issues Multiple Safety Alerts, Updates

ACIP Updates Poliovirus Vaccination Recommendations

Research Network Seeks Evidence to Support Collaborative Care

Vaccines & Immunizations Special Report

ACIP Issues Targeted Recommendations for H1N1 Vaccinations

CDC Pushes Seasonal Flu Shots for Kids Ages 6 Months to 18 Years